Anger as Spain boosts R&D figures with defence money


detect subtle differences between strains; the public project will give a more complete view of one strain. But Celera president Craig Venter sees duplication, not difference. The consortium’s effort is a “waste of public money”, he says. “It would make more sense for scientists to pay for Celera licences than to pay for the genome to be sequenced again… (More)
DOI: 10.1038/35037775


  • Presentations referencing similar topics